Table 2.
Number of virus-positive patients and virus distribution between treatment groups*
| n VP patients* | RSV | Corona 229E | Corona OC43 | hMPV | hRV | Influenza A | PIV3 | |
|---|---|---|---|---|---|---|---|---|
|
ITT |
118/203 |
4 |
32 |
21 |
5 |
60 |
13 |
1 |
|
V |
59/102 |
3 |
16 |
13 |
2 |
27 |
7 |
0 |
| P | 59/101 | 1 | 16 | 8 | 3 | 33 | 6 | 1 |
*Some patients had more than one virus.
hMPV = Human metapneumovirus; hRV = Human rhinovirus; ITT = Intention to treat population; P = Placebo; PIV3 = Parainfluenza virus type 3; V = Carrageenan; VP = Virus-positive patients.